BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15916792)

  • 1. Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome.
    Gray L; Sterjovski J; Churchill M; Ellery P; Nasr N; Lewin SR; Crowe SM; Wesselingh SL; Cunningham AL; Gorry PR
    Virology; 2005 Jul; 337(2):384-98. PubMed ID: 15916792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
    Joly M; Pinto JM
    Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates.
    Laurén A; Vincic E; Hoshino H; Thorstensson R; Fenyö EM
    Retrovirology; 2007 Jul; 4():50. PubMed ID: 17645788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.
    Gorry PR; Bristol G; Zack JA; Ritola K; Swanstrom R; Birch CJ; Bell JE; Bannert N; Crawford K; Wang H; Schols D; De Clercq E; Kunstman K; Wolinsky SM; Gabuzda D
    J Virol; 2001 Nov; 75(21):10073-89. PubMed ID: 11581376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
    Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
    J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of HIV coreceptor tropism.
    Hoffmann C
    Eur J Med Res; 2007 Oct; 12(9):385-90. PubMed ID: 17933718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.
    Wade J; Sterjovski J; Gray L; Roche M; Chiavaroli L; Ellett A; Jakobsen MR; Cowley D; Pereira Cda F; Saksena N; Wang B; Purcell DF; Karlsson I; Fenyö EM; Churchill M; Gorry PR
    Virology; 2010 Jan; 396(2):246-55. PubMed ID: 19913863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
    Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
    Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.
    Ariën KK; Gali Y; El-Abdellati A; Heyndrickx L; Janssens W; Vanham G
    Virology; 2006 Mar; 347(1):65-74. PubMed ID: 16386774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1.
    Olivieri K; Scoggins RM; Bor YC; Matthews A; Mark D; Taylor JR; Chernauskas D; Hammarskjöld ML; Rekosh D; Camerini D
    Virology; 2007 Feb; 358(1):23-38. PubMed ID: 16999983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa.
    Meng G; Sellers MT; Mosteller-Barnum M; Rogers TS; Shaw GM; Smith PD
    J Infect Dis; 2000 Sep; 182(3):785-91. PubMed ID: 10950772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
    Karlsson I; Grivel JC; Chen SS; Karlsson A; Albert J; Fenyö EM; Margolis LB
    J Virol; 2005 Sep; 79(17):11151-60. PubMed ID: 16103166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines.
    Wang J; Crawford K; Yuan M; Wang H; Gorry PR; Gabuzda D
    J Infect Dis; 2002 Apr; 185(7):885-97. PubMed ID: 11920312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.
    Mild M; Esbjörnsson J; Fenyö EM; Medstrand P
    J Virol; 2007 Apr; 81(7):3369-76. PubMed ID: 17251288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.
    Yi Y; Isaacs SN; Williams DA; Frank I; Schols D; De Clercq E; Kolson DL; Collman RG
    J Virol; 1999 Sep; 73(9):7117-25. PubMed ID: 10438797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.